The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of cytoreductive surgery on survival outcomes for recurrent adult-type granulosa cell tumors of the ovary.
 
Jeffrey How
Research Funding - Merck
(OPTIONAL) Uncompensated Relationships - Precare
 
Alejandra Flores Legarreta
No Relationships to Disclose
 
Bryan M. Fellman
No Relationships to Disclose
 
Katelyn Handley
No Relationships to Disclose
 
Katherine Foster
Research Funding - Karyopharm Therapeutics (Inst)
 
Deanna Glassman
No Relationships to Disclose
 
Barrett Lawson
No Relationships to Disclose
 
Lois M. Ramondetta
No Relationships to Disclose
 
David Marc Gershenson
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson; Procter & Gamble
Consulting or Advisory Role - AADi; Genentech; Onconova Therapeutics; SpringWorks Therapeutics; Verastem
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Elsevier as book editor; Royalties from UpToDate for authorship
 
Anil K Sood
Employment - Amgen (I)
Stock and Other Ownership Interests - Bio-Path Holdings
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - GlaxoSmithKline (I); Iylon; KIYATEC; Merck
Research Funding - MTrap
Patents, Royalties, Other Intellectual Property - EGFL6 antibody royalty payment; SiRNA delivery (patents on DOPC, rHDL)
(OPTIONAL) Uncompensated Relationships - Elsevier
 
Robert Tyler Hillman
Research Funding - Sumitomo Dainippon Pharma Oncology